Last update 01 Nov 2024
Wanbangde Pharmaceutical Holding Group Co., Ltd.

Wanbangde Pharmaceutical Holding Group Co., Ltd.

Public Company|
1999|
Zhejiang Sheng, China
|
1,000-5,000
| SHE: 002082|
www.wepon.com.cn

Overview

Tags

Nervous System Diseases
Other Diseases
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Immune System Diseases2
Endocrinology and Metabolic Disease1
Infectious Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
AChE x NMDA receptor1
SCNA(Sodium voltage-gated channel alpha subunits)1

Related

2
Drugs associated with Wanbangde Pharmaceutical Holding Group Co., Ltd.
Huperzine A
Target
AChE x NMDA receptor
Mechanism
AChE inhibitors [+1]
Active Org.
Wanbangde Pharmaceutical Holding Group Co., Ltd.Wanbangde Pharmaceutical Holding Group Co., Ltd. [+9]
Originator Org.
Mayo ClinicMayo Clinic
Active Indication
Alzheimer Disease [+8]
Inactive Indication
Brain Injuries, Traumatic [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 1994
Ambroxol Hydrochloride
Target
SCNA
Mechanism
SCNA modulators
Active Org.
Shanxi Yanghe Pharmaceutical Technology Co., Ltd. [+32]
Originator Org.
Teijin Pharma Ltd.
Active Indication
Chronic sinusitis [+22]
Inactive Indication
Acute pharyngitis
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date27 May 1983
27
Clinical Trials associated with Wanbangde Pharmaceutical Holding Group Co., Ltd.
NCT06570655 / Active, not recruitingPhase 1
The Study of Pharmacokinetics and Pharmacodynamics of Huperzine A Injection in Healthy Chinese Subjects
CTR20231010 / CompletedNot Applicable
头孢克洛颗粒随机、开放、单剂量、两制剂在中国健康受试者中的生物等效性正式试验
[Translation] A randomized, open-label, single-dose, formal bioequivalence study of two formulations of cefaclor granules in Chinese healthy subjects
NCT05560373 / Not yet recruitingPhase 4
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
100 Clinical Results associated with Wanbangde Pharmaceutical Holding Group Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Wanbangde Pharmaceutical Holding Group Co., Ltd.
Login to view more data
100 Deals associated with Wanbangde Pharmaceutical Holding Group Co., Ltd.
Login to view more data
100 Translational Medicine associated with Wanbangde Pharmaceutical Holding Group Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Phase 3 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ambroxol Hydrochloride
 ( SCNA )		Chronic lung disease
More
Phase 3
Huperzine A
 ( AChE x NMDA receptor )		Memory Disorders
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free